1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Comparison of unnecessary FNA rates for thyroid cancer diagnosis in all nodulesa
No. of FNAs No. of Malignant Nodules among FNA Nodules No. of Benign Nodules among FNA Nodules Unnecessary FNA Rate CAD based on K-TIRADS (categories 3, 4, and 5) 85.5 (388/454) 42.0 (163/388) 58.0 (225/388) 49.6 (225/454) CAD based on K-TIRADS (categories 4 and 5) 64.3 (292/454) 51.0 (149/292) 49.0 (143/292) 31.5 (143/454) CAD based on ATA-TIRADS (categories 3, 4, and 5) 79.3 (360/454) 43.9 (158/360) 56.1 (202/360) 44.5 (202/454) CAD based on ATA-TIRADS (categories 4 and 5) 55.3 (251/454) 57.5 (146/254) 42.5 (108/254) 23.8 (108/454) CAD based on possible diagnosis 41.4 (188/454) 72.3 (136/188) 27.7 (52/188) 11.5 (52/454) Radiologist K-TIRADS (categories 3, 4, and 5) 76.2 (346/454) 47.1 (163/346) 52.9 (183/346) 40.3 (183/454) Radiologist K-TIRADS (categories 4 and 5) 48.5 (220/454) 69.5 (153/220) 30.5 (67/220) 14.8 (67/454) Radiologist ATA-TIRADS (categories 3, 4, and 5) 68.3 (310/454) 48.4 (150/310) 51.6 (160/310) 35.2 (160/454) Radiologist ATA-TIRADS (categories 4 and 5) 43.0 (195/454) 71.8 (140/195) 28.2 (55/195) 12.1 (55/454) Radiologist based on possible diagnosis 32.8 (149/454) 91.9 (137/149) 8.1 (12/149) 2.6 (12/454)
↵a The numbers are percentages. Categories 5, 4, and 3 refer to high-, intermediate-, and low-suspicion nodules in each guideline.